Peak TRV Risk Stratification Calculator (Echocardiography Pulmonary Hypertension Assessment)
Echocardiographic assessment
Enter peak tricuspid regurgitation velocity and estimated right atrial pressure.
Use the highest technically valid peak TRV measured by continuous-wave Doppler.
Choose the RAP estimate supported by your echocardiographic assessment. The 10 mmHg option preserves the original tool default.
| Parameter | Result | Notes |
|---|---|---|
| Peak TRV | — | Continuous-wave Doppler measurement |
| Estimated SPAP | — | 4 × TRV² + estimated RAP |
| Other PH signs | Not assessed | Signs in at least two categories are needed to modify probability in the ESC/ERS algorithm |
SPAP is an estimate and is sensitive to RAP estimation and TRV measurement error. It is not, by itself, a diagnostic classification.
Clinical interpretation
Peak tricuspid regurgitation velocity (TRV) is used to assign echocardiographic probability of pulmonary hypertension (PH). A TRV above 2.8 m/s may suggest PH, but TRV alone cannot reliably confirm or exclude it. Interpret the result with symptoms, risk factors, and the complete echocardiogram.
How probability is assigned
- TRV ≤2.8 m/s or unmeasurable: low probability when additional PH signs are absent; intermediate when qualifying additional signs are present.
- TRV 2.9–3.4 m/s: intermediate probability when additional signs are absent; high when qualifying additional signs are present.
- TRV >3.4 m/s: high echocardiographic probability.
Estimated systolic pulmonary artery pressure
SPAP = 4 × TRV² + RAP. This uses the simplified Bernoulli equation to estimate the tricuspid regurgitation pressure gradient, then adds estimated right atrial pressure. In the ESC/ERS guideline, peak TRV—not estimated SPAP—is the key variable for assigning echocardiographic probability because RAP estimation and derived pressure estimates have limitations.
Additional echocardiographic signs
Examples include RV/LV basal diameter or area ratio >1.0, septal flattening, TAPSE/SPAP ratio <0.55 mm/mmHg, RVOT acceleration time <105 ms or mid-systolic notching, pulmonary artery enlargement, and a dilated IVC with reduced inspiratory collapse or enlarged right atrial area. Signs must be present in at least two of the guideline's three categories to alter probability.
Reference
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.